{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-177024","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2025-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.673695+00:00","generated_at":"2026-05-17T16:12:48.390586+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ImmunityBio reaches preliminary settlement in shareholder derivative lawsuit","bullets":["Court preliminarily approved derivative settlement on July 29, 2025, with final hearing set for Nov 4, 2025.","Settlement requires ImmunityBio to adopt corporate governance reforms including a new independent director and enhanced compliance.","Attorneys' fees not to exceed $1.4 million will be paid by insurance; no monetary payment to shareholders.","Governance reforms include quarterly board updates on FDA/cGMP compliance and annual legal department reviews.","Settlement resolves derivative actions related to alleged oversight failures and misleading statements about Anktiva BLA."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-177024","json":"https://secwatch.observer/filing/0001193125-25-177024.json","markdown":"https://secwatch.observer/filing/0001193125-25-177024.md","text":"https://secwatch.observer/filing/0001193125-25-177024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525177024/0001193125-25-177024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525177024/d29656d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T16:12:48.390586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}